Go Pro
NASDAQ:SBC

SBC Medical Group (SBC) Stock Price, News & Analysis

SBC Medical Group logo
$4.43 +0.31 (+7.52%)
Closing price 09/8/2026 04:00 PM Eastern
Extended Trading
$4.18 -0.25 (-5.53%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About SBC Medical Group Stock (NASDAQ:SBC)

Advanced

Key Stats

Today's Range
$4.14
$4.45
50-Day Range
$2.93
$4.43
52-Week Range
$2.78
$5.00
Volume
213,163 shs
Average Volume
197,268 shs
Market Capitalization
$455.61 million
P/E Ratio
9.43
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Hold

Company Overview

SBC Medical Group, Inc. is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services. SBC Medical Group leverages proprietary software platforms and workflow automation tools to manage patient registration, claims submission and payment reconciliation. By integrating clinical documentation improvement and audit support, the company aims to reduce denials, accelerate cash collections and ensure adherence to regulatory requirements.

Operating across the United States, SBC Medical Group partners with a range of specialties including diagnostic imaging, physical therapy, laboratory services and radiation therapy providers. The company’s end-to-end service model is tailored to the specific needs of each client, enabling faster onboarding of new sites and scalability as practices expand. SBC Medical Group’s leadership team brings experience from healthcare operations, technology development and financial services to drive growth and operational excellence.

AI Generated. May Contain Errors.

SBC Medical Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

SBC MarketRank™: 

SBC Medical Group scored higher than 84% of companies evaluated by MarketBeat, and ranked 84th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SBC Medical Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    SBC Medical Group has a consensus price target of $8.50, representing about 91.9% upside from its current price of $4.43.

  • Amount of Analyst Coverage

    SBC Medical Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about SBC Medical Group's stock forecast and price target.
  • Earnings Growth

    Earnings for SBC Medical Group are expected to grow by 18.18% in the coming year, from $0.44 to $0.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SBC Medical Group is 9.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SBC Medical Group is 9.43, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 270.60.

  • Price to Book Value per Share Ratio

    SBC Medical Group has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about SBC Medical Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.58% of the float of SBC Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    SBC Medical Group has a short interest ratio ("days to cover") of 4.65.
  • Change versus previous month

    Short interest in SBC Medical Group has recently decreased by 17.13%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SBC Medical Group does not currently pay a dividend.

  • Dividend Growth

    SBC Medical Group does not have a long track record of dividend growth.

  • News Sentiment

    SBC Medical Group has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for SBC Medical Group this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for SBC on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SBC Medical Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    81.70% of the stock of SBC Medical Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    60.82% of the stock of SBC Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about SBC Medical Group's insider trading history.
Receive SBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SBC Medical Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBC Stock News Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
SBC Medical (SBC) Q2 2026 Earnings Call Transcript
See More Headlines

SBC Stock Analysis - Frequently Asked Questions

SBC Medical Group's stock was trading at $4.31 on January 1st, 2026. Since then, SBC shares have increased by 2.8% and is now trading at $4.43.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) issued its quarterly earnings results on Thursday, August, 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by $0.02. The firm had revenue of $49.19 million for the quarter, compared to analysts' expectations of $45.37 million. SBC Medical Group had a net margin of 27.99% and a trailing twelve-month return on equity of 18.47%.
Read the conference call transcript
.

Top institutional investors of SBC Medical Group include BlackRock Inc. (0.90%), Citadel Advisors LLC (0.14%), Bank of New York Mellon Corp (0.03%) and Central Pacific Bank Trust Division (0.02%).
View institutional ownership trends
.

Shares of SBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SBC Medical Group investors own include Mastech Digital (MHH), Phoenix Motor (PEV), Agora (API) and American Outdoor Brands (AOUT).

Company Calendar

Last Earnings
8/13/2026
Today
9/08/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:SBC
Previous Symbol
NASDAQ:SBC
CIK
1930313
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$8.00
Potential Upside/Downside
+91.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.47
Trailing P/E Ratio
9.43
Forward P/E Ratio
10.07
P/E Growth
N/A
Net Income
$50.99 million
Net Margins
27.99%
Pretax Margin
43.09%
Return on Equity
18.47%
Return on Assets
13.10%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
3.31
Quick Ratio
3.27

Sales & Book Value

Annual Sales
$175.17 million
Price / Sales
2.60
Cash Flow
$0.56 per share
Price / Cash Flow
7.87
Book Value
$2.57 per share
Price / Book
1.72

Miscellaneous

Outstanding Shares
102,847,000
Free Float
18,821,000
Market Cap
$455.61 million
Optionable
N/A
Beta
0.63

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SBC) was last updated on 9/9/2026 by MarketBeat.com Staff.
From Our Partners